Product Code: GVR-4-68040-381-1
Cardiac Mapping Devices Market Growth & Trends:
The global cardiac mapping devices market size is expected to reach USD 3.69 billion by 2030, registering a CAGR of 9.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. The primary factors driving the market expansion include the rising arrhythmia cases & number of cardiac surgery patients, growing geriatric population, technological advancements in cardiac mapping systems, and supportive government initiatives. According to the Heart Rhythm Society article published in August 2023, Atrial fibrillation (AFib), the most common type of cardiac arrhythmia, affects nearly 40 million people worldwide, including 6 million in the U.S. Its widespread prevalence underscores the need for advanced diagnostic and treatment options.
Approximately 1 in 4 adults over 40 are at risk of developing AFib, yet many are unaware of its symptoms, available treatments, and the importance of early intervention to prevent progression. Advancements in cardiac mapping systems also drive market growth. For instance, in June 2024, new mapping techniques, such as multielectrode baskets and catheters mapping across cardiac arteries and veins on the epicardium, enabled three-dimensional activation sequence definition during vacuum therapy. Computerized non-contact mapping uses mathematical algorithms to reconstruct electrograms and generate three-dimensional isopotential maps without direct heart endocardium contact.
Advances in remote monitoring and infection prevention in cardiac electrophysiology support continuous patient heart rhythm monitoring outside clinical settings, allowing prompt treatment adjustments and reducing invasive procedure infection risks. Moreover, several strategic initiatives by key players fuel the market's growth. For instance, in July 2024, Johnson & Johnson's Biosense Webster launched the Optrell mapping catheter, incorporating TrueRef technology. Designed in Irvine, California, by Biosense Webster, Optrell is a high-density diagnostic catheter that integrates with the Carto 3 system. It utilizes small electrodes in a fixed array configuration to provide accurate electrophysiological mapping for complex cardiac arrhythmias.
Cardiac Mapping Devices Market Report Highlights:
- The contact cardiac mapping systems segment held the largest share of over 57.07%, in 2023 due to technological advancements, strategic initiatives by key players, and a rising volume of cardiac procedures
- The atrial fibrillation segment held the largest share of over 45.87% in 2023 due to increased cases of arrhythmia and high geriatric population
- The hospitals segment held the largest share of 69.38% in 2023. Hospitals play a vital role in adopting and assessing new technologies, such as advanced cardiac mapping devices. These devices enable hospitals to deliver state-of-the-art care for patients with cardiac arrhythmias, ensuring better outcomes and advancing the field of electrophysiology
- North America dominated the global market with a share of 41.39% in 2023 owing to the increased cases of cardiovascular diseases (CVDs), including arrhythmias. Product launches, regulatory approvals, and advanced healthcare infrastructure
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Type
- 1.2.2. Indication
- 1.2.3. End-use
- 1.2.4. Regional scope
- 1.2.5. Estimates and forecast timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity price analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Type Segment
- 2.2.2. Indication Segment
- 2.2.3. End-use Segment
- 2.2.4. Regional Outlook
- 2.3. Competitive Insights
Chapter 3. Global Cardiac Mapping Devices Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Increasing number of cardiac surgery patients
- 3.2.1.2. Rising arrhythmia cases
- 3.2.1.3. Technological advancements in mapping systems
- 3.2.1.4. Growing number of cardiovascular diseases (CVD)
- 3.2.1.5. Rising geriatric population
- 3.2.2. Market restraint analysis
- 3.2.2.1. High cost of cardiac mapping systems
- 3.2.2.2. Lack of adequate infrastructure
- 3.3. Cardiac Mapping Devices Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
Chapter 4. Cardiac Mapping Devices Market: Type Estimates & Trend Analysis
- 4.1. Cardiac Mapping Devices Market: Type Dashboard
- 4.2. Cardiac Mapping Devices Market: Type Movement Analysis
- 4.3. Cardiac Mapping Devices Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
- 4.4. Contact cardiac mapping systems
- 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 4.5. Non-contact cardiac mapping systems
- 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Cardiac Mapping Devices Market: Indication Estimates & Trend Analysis
- 5.1. Cardiac Mapping Devices Market: Indication Dashboard
- 5.2. Cardiac Mapping Devices Market: Indication Movement Analysis
- 5.3. Cardiac Mapping Devices Market Size & Forecasts and Trend Analysis, by Indication, 2018 to 2030 (USD Million)
- 5.4. Atrial Fibrillation
- 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 5.5. Atrial Flutter
- 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 5.6. Others
- 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Cardiac Mapping Devices Market: End Use Estimates & Trend Analysis
- 6.1. Cardiac Mapping Devices Market: End Use Dashboard
- 6.2. Cardiac Mapping Devices Market: End Use Movement Analysis
- 6.3. Cardiac Mapping Devices Market Size & Forecasts and Trend Analysis, by End-use, 2018 to 2030 (USD Million)
- 6.4. Hospitals
- 6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 6.5. Diagnostic Centers
- 6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
- 6.6. Others
- 6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Cardiac Mapping Devices Market: Regional Estimates & Trend Analysis by Country, Type, End-use, & End Use
- 7.1. Global Cardiac Mapping Devices Market: Regional Dashboard
- 7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
- 7.3. North America
- 7.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.3.2. U.S.
- 7.3.2.1. Key country dynamics
- 7.3.2.2. Regulatory framework/reimbursement structure
- 7.3.2.3. Competitive scenario
- 7.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3.3. Canada
- 7.3.3.1. Key country dynamics
- 7.3.3.2. Regulatory framework/ reimbursement structure
- 7.3.3.3. Competitive scenario
- 7.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3.4. Mexico
- 7.3.4.1. Key country dynamics
- 7.3.4.2. Regulatory framework/ reimbursement structure
- 7.3.4.3. Competitive scenario
- 7.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4. Europe
- 7.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.4.2. UK
- 7.4.2.1. Key country dynamics
- 7.4.2.2. Regulatory framework/ reimbursement structure
- 7.4.2.3. Competitive scenario
- 7.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.3. Germany
- 7.4.3.1. Key country dynamics
- 7.4.3.2. Regulatory framework/ reimbursement structure
- 7.4.3.3. Competitive scenario
- 7.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.4. France
- 7.4.4.1. Key country dynamics
- 7.4.4.2. Regulatory framework/ reimbursement structure
- 7.4.4.3. Competitive scenario
- 7.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.5. Italy
- 7.4.5.1. Key country dynamics
- 7.4.5.2. Regulatory framework/ reimbursement structure
- 7.4.5.3. Competitive scenario
- 7.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.6. Spain
- 7.4.6.1. Key country dynamics
- 7.4.6.2. Regulatory framework/ reimbursement structure
- 7.4.6.3. Competitive scenario
- 7.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.7. Sweden
- 7.4.7.1. Key country dynamics
- 7.4.7.2. Regulatory framework/ reimbursement structure
- 7.4.7.3. Competitive scenario
- 7.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.8. Norway
- 7.4.8.1. Key country dynamics
- 7.4.8.2. Regulatory framework/ reimbursement structure
- 7.4.8.3. Competitive scenario
- 7.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.9. Denmark
- 7.4.9.1. Key country dynamics
- 7.4.9.2. Regulatory framework/reimbursement structure
- 7.4.9.3. Competitive scenario
- 7.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
- 7.5. Asia Pacific
- 7.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.5.2. China
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Regulatory framework/ reimbursement structure
- 7.5.2.3. Competitive scenario
- 7.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
- 7.5.3. Japan
- 7.5.3.1. Key country dynamics
- 7.5.3.2. Regulatory framework/ reimbursement structure
- 7.5.3.3. Competitive scenario
- 7.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
- 7.5.4. India
- 7.5.4.1. Key country dynamics
- 7.5.4.2. Regulatory framework/ reimbursement structure
- 7.5.4.3. Competitive scenario
- 7.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
- 7.5.5. Australia
- 7.5.5.1. Key country dynamics
- 7.5.5.2. Regulatory framework/ reimbursement structure
- 7.5.5.3. Competitive scenario
- 7.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
- 7.5.6. Thailand
- 7.5.6.1. Key country dynamics
- 7.5.6.2. Regulatory framework/ reimbursement structure
- 7.5.6.3. Competitive scenario
- 7.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
- 7.5.7. South Korea
- 7.5.7.1. Key country dynamics
- 7.5.7.2. Regulatory framework/ reimbursement structure
- 7.5.7.3. Competitive scenario
- 7.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6. Latin America
- 7.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.6.2. Brazil
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Regulatory framework/ reimbursement structure
- 7.6.2.3. Competitive scenario
- 7.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.3. Argentina
- 7.6.3.1. Key country dynamics
- 7.6.3.2. Regulatory framework/ reimbursement structure
- 7.6.3.3. Competitive scenario
- 7.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7. MEA
- 7.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.7.2. Saudi Arabia
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Regulatory framework/ reimbursement structure
- 7.7.2.3. Competitive scenario
- 7.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7.3. South Africa
- 7.7.3.1. Key country dynamics
- 7.7.3.2. Regulatory framework/ reimbursement structure
- 7.7.3.3. Competitive scenario
- 7.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7.4. UAE
- 7.7.4.1. Key country dynamics
- 7.7.4.2. Regulatory framework/ reimbursement structure
- 7.7.4.3. Competitive scenario
- 7.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7.5. Kuwait
- 7.7.5.1. Key country dynamics
- 7.7.5.2. Regulatory framework/ reimbursement structure
- 7.7.5.3. Competitive scenario
- 7.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Manufacturers
- 8.2. Company/Competition Categorization
- 8.3. Vendor Landscape
- 8.3.1. List of key distributors and channel partners
- 8.3.2. Key customers
- 8.3.3. Key company market share analysis, 2023
- 8.3.4. Abbott
- 8.3.4.1. Company overview
- 8.3.4.2. Financial performance
- 8.3.4.3. Product benchmarking
- 8.3.4.4. Strategic initiatives
- 8.3.5. Medtronic
- 8.3.5.1. Company overview
- 8.3.5.2. Financial performance
- 8.3.5.3. Product benchmarking
- 8.3.5.4. Strategic initiatives
- 8.3.6. BIOTRONIK
- 8.3.6.1. Company overview
- 8.3.6.2. Financial performance
- 8.3.6.3. Product benchmarking
- 8.3.6.4. Strategic initiatives
- 8.3.7. Acutus Medical
- 8.3.7.1. Company overview
- 8.3.7.2. Financial performance
- 8.3.7.3. Product benchmarking
- 8.3.7.4. Strategic initiatives
- 8.3.8. APN Health, LLC
- 8.3.8.1. Company overview
- 8.3.8.2. Financial performance
- 8.3.8.3. Product benchmarking
- 8.3.8.4. Strategic initiatives
- 8.3.9. Johnson & Johnson
- 8.3.9.1. Company overview
- 8.3.9.2. Financial performance
- 8.3.9.3. Product benchmarking
- 8.3.9.4. Strategic initiatives
- 8.3.10. Biosig Technologies, Inc.
- 8.3.10.1. Company overview
- 8.3.10.2. Financial performance
- 8.3.10.3. Product benchmarking
- 8.3.10.4. Strategic initiatives
- 8.3.11. Boston Scientific Corporation
- 8.3.11.1. Company overview
- 8.3.11.2. Financial performance
- 8.3.11.3. Product benchmarking
- 8.3.11.4. Strategic initiatives
- 8.3.12. Kardium, Inc.
- 8.3.12.1. Company overview
- 8.3.12.2. Financial performance
- 8.3.12.3. Product benchmarking
- 8.3.12.4. Strategic initiatives
- 8.3.13. Koninklijke Philips N.V
- 8.3.13.1. Company overview
- 8.3.13.2. Financial performance
- 8.3.13.3. Product benchmarking
- 8.3.13.4. Strategic initiatives
- 8.3.14. Microport Scientific Corporation
- 8.3.14.1. Company overview
- 8.3.14.2. Financial performance
- 8.3.14.3. Product benchmarking
- 8.3.14.4. Strategic initiatives